QTREX CEO buys 168,894 shares

What happened

QTREX Quantum Ltd. (NASDAQ: QTEX) said Chief Executive Officer and director Dagi Shahar Ben-Noon bought 168,894 ordinary shares on 2026-09-28. The Form 4 was signed on 2026-09-29 and codes the transaction as a purchase in the open market.

The filing puts the weighted average price at $0.7078 a share, with trades ranging from $0.6897 to $0.7200. The purchase totaled about $119,543, and Ben-Noon held 3,646,133 shares afterward. The shares were bought as part of the management share purchase plan announced on June 22, 2026.

Key numbers

Metric	Latest	Change	Source
Shares purchased	168,894 shares		SEC Form 4
Weighted average price	$0.7078		SEC Form 4
Purchase price range	$0.6897 to $0.7200		SEC Form 4
Purchase total	about $119,543		SEC Form 4
Shares held after purchase	3,646,133 shares		SEC Form 4

Read more: QTREX Quantum (QTEX) stock analysis and investment case

Why it matters

OptimistFi's case is that QTEX is a development-stage commercialization bet, so ownership changes matter because they show how management backs the story. This filing strengthens that lens because the company's CEO added to his stake rather than trimming it. It also gives investors a reference point for the next Form 4 from the same insider.

OptimistFi's calculation puts the 168,894 shares at about 4.9% of the holding before the trade. Before the buy, he held 3,477,239 shares, so the latest purchase changes the benchmark for future filings. That is a notable add to a direct stake, but it is still one transaction and not evidence of revenue, margins or adoption.

Browse: stock research on every company OptimistFi covers

What's next

The caveat is that the filing records a personal buy, not an operating result. The management share purchase plan explains the setting, but investors still need later filings to judge the business. The next quarterly report will be the next scheduled check on whether this purchase lines up with operating progress.

Better evidence of repeatable revenue or improved margins would support the case, while weaker follow-through would leave the trade as a management signal. If the report is stronger, it supports the buy as a timely signal. If not, the trade stands on its own. That makes the filing useful as a baseline for the next update, not a verdict.

More from OptimistFi